Cardinal health reports second quarter fiscal year 2025 results and raises fiscal year 2025 outlook

Revenue decreased 4% to $55.3 billion; revenue increased 16% excluding the impact of the previously communicated large customer contract expiration gaap 1 operating earnings were $549 million; gaap diluted eps was $1.65 non-gaap operating earnings increased 9% to $635 million, driven by the pharmaceutical and specialty solutions segment; non-gaap diluted eps increased 2% to $1.93 fiscal year 2025 non-gaap eps guidance2 raised to $7.85 to $8.00, from $7.75 to $7.90 company announces the completion of its acquisition of 73% ownership of gi alliance dublin, ohio , jan. 30, 2025 /prnewswire/ -- cardinal health (nyse: cah) today reported second quarter fiscal year 2025 revenues of $55.3 billion, a decrease of 4% from the second quarter of fiscal year 2024. second quarter revenue increased 16% excluding the impact of the previously communicated large customer contract expiration.
CAH Ratings Summary
CAH Quant Ranking